Kahuna Workforce Solutions has officially deployed its platform at Memorial Hermann Health System. Photo via RSM Design

More than 14,000 nurses at one of the largest nonprofit health care providers in Texas have access to a new skills and competency management software.

Kahuna Workforce Solutions has officially deployed its platform at Memorial Hermann Health System, consisting of 17 hospitals and more than 250 care delivery sites. The platform will streamline onboarding processes and increase transparency and accessibility for staff.

“Kahuna will enhance our clinical competency experience and fully aligns with our nursing strategy to optimize our processes, prioritize innovation and safety, and excel as a top provider of care and clinical advancement for clinicians,” Bryan Sisk, senior vice president and chief nursing executive for Memorial Hermann, says in a news release.

“Memorial Hermann is committed to the Houston community and helping to develop the next generation of nurses,” Sisk continues. “The Kahuna platform will help improve the transparency, autonomy and efficiency of our competency management and development processes for our nurses to better support them in their roles, while also ensuring we provide high-quality care for our patients.”

The rollout comes six months after the software-as-a-service company raised a $21 million series B round of funding.

“We are thrilled to work with Memorial Hermann as they enrich all aspects of their clinical competency management practices with Kahuna’s skills management software,” adds Jai Shah, CEO of Kahuna Workforce Solutions. “This collaboration unites two Houston-based organizations and demonstrates a joint commitment to enhancing the standard of health care through digitized competency management in our Houston community and far beyond.”

This week's roundup of Houston innovators includes Jai Shah of Kahuna, Cindy Taff of Sage Geosystems, and Patrick Flam of Revterra. Photos courtesy

3 Houston innovators to know this week

who's who

Editor's note: Each week, I'm introducing you to three Houston innovators to know — three individuals behind recent innovation and startup news stories in Houston as reported by InnovationMap. Learn more about them and their recent news below by clicking on each article.

Jai Shah, CEO of Kahuna Workforce Solutions

Kahuna CEO Jai Shah shares how he plans on deploying the $21 million his Houston company just raised. Photo courtesy of Kahuna

With a recent $21 million series B funding round set to fuel more growth and expand an impressive client roster, Kahuna Workforce Solutions is riding a big wave into 2024.

CEO Jai Shah tells InnovationMap that the Houston skills management software service company’s Hawaiian name captures their style.

“Kahuna is that kind of expert, competent leader in a tribe or family,” Jai says. “That’s all because we had this concept of really wanting to be providing a very..family-oriented consulting approach. Treat our customers like family, and with respect, love and really just try and deliver on that promise.” Continue reading.

Cindy Taff, CEO of Sage Geosystems

Cindy Taff of Sage Geosystems explains why she's so optimistic about geothermal and her company's technology. Photo courtesy of Sage

Geothermal energy is an integral part of decarbonizing the energy industry, and Sage Geosystems CEO Cindy Taff believes her company's tech has what it takes to lead the way.

Founded in Houston in 2020, Sage Geosystems is focused on two business lines — energy storage and geothermal. In addition to developing these technologies, Taff says Sage has "cracked the code" on both reducing costs and maximizing electricity output. Sage has customers ranging from Nabors, the world’s largest land-based drilling company, and Virya LLC, an investor in climate ventures with high impact of eliminating global greenhouse gas emissions or sequestering CO2. Continue reading.

Patrick Flam, CFO of Revterra

Revterra was selected from among 10 finalists receiving up to $1 million piloting opportunities. Photo via ADNOC

Revterra, which produces novel batteries made from recycled steel, has been awarded a million-dollar piloting opportunity by ADNOC following a global competition. The ADNOC Decarbonization Technology Challenge, in collaboration with AWS, bp, Hub71, and the Net Zero Technology Centre, sought to find emerging climate tech innovations that are ready for scale.

At the event in Dubai, Revterra was selected from among 10 finalists receiving up to $1 million piloting opportunities. In addition to the $1 million, they will gain access to facilities and expertise at the ADNOC Research and Innovation Center in Abu Dhabi.

“We are thrilled to win this opportunity,” Patrick Flam, CFO of Revterra, says in a news release. “At Revterra, we have developed an environmentally friendly battery that doesn’t rely on metals like lithium, nickel, or cobalt.” Continue reading.

Kahuna CEO Jai Shah shares how he plans on deploying the $21 million his Houston company just raised. Photo courtesy of Kahuna

Houston HR tech platform plans to grow team, expand internationally with recent $21M raise

big kahuna

With a recent $21 million series B funding round set to fuel more growth and expand an impressive client roster, Kahuna Workforce Solutions is riding a big wave into 2024.

CEO Jai Shah tells InnovationMap that the Houston skills management software service company’s Hawaiian name captures their style.

“Kahuna is that kind of expert, competent leader in a tribe or family,” Jai says. “That’s all because we had this concept of really wanting to be providing a very..family-oriented consulting approach. Treat our customers like family, and with respect, love and really just try and deliver on that promise.”

For Shah, Kahuna represents a natural progression, and grew out of his first startup, Hula Partners, a Houston consulting company acquired by GP Strategies Corp. in 2017.

Shah says his initial work in human resource technology transformation for energy giants like Marathon Oil exposed the poor functionality of HR software, especially for employees. The very technology that has revolutionized the workplace has often not met the needs of many American workers, even as they face more demands on their time.

“We saw a need in the marketplace, relative to the consulting, where technology really wasn’t filling the gap,” says Shah, who now lives in San Diego.

Kahuna’s skills management software service bridges that gap, enabling employees train and grow within their field, and employers to track and monitor their progress in key competencies.

Whether it’s a nurse assessing a patient, or a worker turning a wrench properly on an oil rig, employers observe those skills and record them in Kahuna’s software.

“What Kahuna does, is give the organization a lot more confidence in their ability to have these workers do their jobs,” Shah says.

Those frontline workers drive the company’s ethos. “That workforce is super key to the economy, and it’s really been undeserved by technology for many years. That’s why we exist,” says Shah.

Kahuna caught the attention of Baltimore, Maryland-based Resolve Growth Partners, which chose Kahuna as the first investment in their second funding group with the series B. Kahuna’s series A funding came from venture capital group Houston Ventures.

Chip Davis, of Houston Ventures, who remains a key figure in Kahuna, says he experienced his “Eureka moment” when he saw how Kahuna could solve a problem that he witnessed firsthand in another company. He had another investment client in the oil industry, that had tons of data, but didn’t know what to do with it. He saw that Kahuna provides a way.

“The type of data that Kahuna developed, is not easy to develop,” Davis says. “It knows not that just that you went to college; it knows how well you did, and it knows how well you’re doing now, and it knows why you’re doing well now."

Shah says Kahuna’s ability to leverage that granular data sets the company apart from other HR applications. And that technology may even extend to the future workforce.

Memorial Hermann, a new customer, is in discussions with Kahuna to implement its software early in the journey for nursing candidates, in secondary education curriculum.

Students as young as seventh grade who aspire to a nursing career, could use Kahuna software to find out what skills they’ll need, and keep

Shah says the funds from Resolve, divided in two tranches, will help grow his staff of 50 employees by 30 percent. He also says he plans three or four major initiatives in product development, such as artificial intelligence and machine learning and developing new software modules.

The company will remain headquartered at its Houston office on upper Kirby, but plans are underway to expand operations in about a year into Northern Europe, where many energy clients do business.

Kahuna will maintain growth with a laser focus on frontline workers, Shah says, and solidify its position as a category leader in the energy, manufacturing, and health care verticals.

“A lot of these companies are being challenged in more technically tough environments,” he says. “We’re drilling for oil in deeper and deeper ocean centers. Nurses are asked to do more these days than they were five years ago, or 10 years ago.”

Kahuna’s move upmarket may bring challenges common to companies making that same progression, with a more sophisticated buying process and the scrutiny that comes with it.

“An upmarket customer wants to know how you can support them. They’re going to examine you, in a way you’re not used to being examined,” Davis says.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.